Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes.
Beltran Ponce SE, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke C, Aldakkak M, Evans DB, Christians K, Paulson ES, Erickson B, Hall WA. Beltran Ponce SE, et al. Among authors: aldakkak m. Pract Radiat Oncol. 2024 Aug 23:S1879-8500(24)00157-7. doi: 10.1016/j.prro.2024.07.001. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 39182645
Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.
de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA. de Ortiz de Choudens S, et al. Among authors: aldakkak m. Cancer Med. 2024 Jan;13(1):e6582. doi: 10.1002/cam4.6582. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38140796 Free PMC article.
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.
Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S. Thalji SZ, et al. Among authors: aldakkak m. Ann Surg. 2023 Dec 1;278(6):e1224-e1231. doi: 10.1097/SLA.0000000000005884. Epub 2023 Apr 20. Ann Surg. 2023. PMID: 37078282
Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.
Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S. Thalji SZ, et al. Among authors: aldakkak m. J Surg Oncol. 2023 Jul;128(1):41-50. doi: 10.1002/jso.27265. Epub 2023 Apr 11. J Surg Oncol. 2023. PMID: 36960919
Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy.
Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A. Hammad AY, et al. Among authors: aldakkak m. JAMA Surg. 2023 Jan 1;158(1):55-62. doi: 10.1001/jamasurg.2022.5696. JAMA Surg. 2023. PMID: 36416848 Free PMC article.
56 results